BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15059540)

  • 1. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
    Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
    Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
    Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].
    Zhou WM; Ping JL; Qian FC; Zhang GL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):843-6. PubMed ID: 19958645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
    Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
    J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [p16 and cyclinD1 protein expression and p16 gene mutation in primary human hepatocellular carcinoma].
    Huang GX; Cheng RX; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):527-30. PubMed ID: 12536530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of p16 gene on carcinogenesis of hepatitis B virus related hepatocellular carcinoma].
    Wang ZW; Peng ZH; Li K; Qiu GQ; Zhang Y; Gu W
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):356-8. PubMed ID: 12921565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma].
    Xia JT; Li W; Liu YJ; Chen LZ; Wu ZF; Zhang LJ; Wang Q
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):918-21. PubMed ID: 18171527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NF-kappaB in hepatocellular carcinoma cell.
    Wang J; Huang Q; Chen M
    Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16.
    Matsuda Y; Yamagiwa S; Takamura M; Honda Y; Ishimoto Y; Ichida T; Aoyagi Y
    Cancer; 2005 Sep; 104(5):1037-44. PubMed ID: 15999366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas].
    Luo D; Liu Q; Su J
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):94-5. PubMed ID: 10488417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
    Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B
    Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma.
    Guo L; Guo Y; Xiao S
    Oncology; 2007; 72(5-6):410-6. PubMed ID: 18196928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
    Dai S; Huang W; Gan X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):299-301. PubMed ID: 10743098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
    Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
    Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.